首页> 外文期刊>BioProcess International >Designing a MAb Purification Process:Based on Bio-Sequential Chromatography
【24h】

Designing a MAb Purification Process:Based on Bio-Sequential Chromatography

机译:设计单克隆抗体纯化工艺:基于生物顺序色谱

获取原文
获取原文并翻译 | 示例
           

摘要

In batch-mode chromatography, operating conditions do not allow full use of the total media capacity (1,2). Bio-Sequential Chromatography (BioSC~R) is an open-loop process for the separation of multicomponent solutions (3). The unique column of the batch mode is replaced by a series of smaller columns (from two to six). This design < maximizes the use of the media without product loss along the process sequences. The BioSC~R Lab automated system is based on the multicolumn chromatography process, designed and provided by Novasep. Studies have been performed to demonstrate the benefits on IgG purity of a downstream process (DSP) monoclonal antibody (MAb) platform with two continuous chromatography steps (4). This note features the outlines of the method used and the qualitative and quantitative results obtained for the product critical quality attributes (CQAs) (Table 2).
机译:在分批模式色谱中,操作条件不允许完全使用总介质容量(1,2)。生物顺序色谱法(BioSC〜R)是用于分离多组分溶液的开环方法(3)。批处理模式的唯一列由一系列较小的列(从2到6)代替。此设计<最大限度地利用了介质,而不会导致工艺顺序上的产品损失。 BioSC〜R Lab自动化系统基于由Novasep设计和提供的多柱色谱过程。已经进行了研究以证明具有两个连续色谱步骤的下游工艺(DSP)单克隆抗体(MAb)平台对IgG纯度的益处(4)。本说明概述了所用方法的概述以及针对产品关键质量属性(CQA)的定性和定量结果(表2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号